Careers Contact
iPierian Closes $22 Million Series B Financing Led By Google Ventures
iPS cell technology enables a new way to model disease biology.
iPierian aims to speed drug development for difficult-to-treat diseases.
Internationally-renowned scientific founders. transforming drug discovery and development